Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04UGJ
|
|||
Drug Name |
PMID29671355-Compound-37
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
INCYTE CORPORATION
|
|||
Structure |
Download2D MOL |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Histone deacetylase 8 (HDAC8) | Target Info | Inhibitor | [1] |
Target's Patent Info | Histone deacetylase 8 (HDAC8) | Target's Patent Info | [1] | |
KEGG Pathway | Alcoholism | |||
Viral carcinogenesis | ||||
Panther Pathway | Wnt signaling pathway | |||
Pathway Interaction Database | Signaling events mediated by HDAC Class I | |||
Reactome | NOTCH1 Intracellular Domain Regulates Transcription | |||
Constitutive Signaling by NOTCH1 PEST Domain Mutants | ||||
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | ||||
HDACs deacetylate histones | ||||
WikiPathways | Integrated Pancreatic Cancer Pathway | |||
Neural Crest Differentiation | ||||
Cell Cycle |
References | Top | |||
---|---|---|---|---|
REF 1 | HDAC inhibitors: a 2013-2017 patent survey.Expert Opin Ther Pat. 2018 Apr 19:1-17. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.